Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

All content curated by

Gail Hecht MD

Scott Cotler MD

Steven Edmundowicz MD, MASGE

See All Experts

Published in Gastroenterology

Journal Scan / Research · February 20, 2022

Namodenoson for the Treatment of NAFLD With or Without NASH

Alimentary Pharmacology & Therapeutics

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Additional Info

Article Citation

Alimentary Pharmacology & Therapeutics

Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis

Aliment. Pharmacol. Ther. 2021 Dec 01;54(11-12)1405-1415, R Safadi, M Braun, A Francis, Y Milgrom, M Massarwa, D Hakimian, W Hazou, A Issachar, Z Harpaz, M Farbstein, I Itzhak, N Lev-Cohain, A Bareket-Samish, MH Silverman, P Fishman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Namodenoson for the Treatment of NAFLD With or Without NASH

Additional Info

Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis

Further Reading

Timing for the Resumption of Direct Oral Anticoagulants Following Colorectal Endoscopic Submucosal Dissection

Assessing Dietary Emulsifier Exposure Among Patients With IBD vs Healthy Controls

Cannabis Use Patterns and Association With Hyperemesis

Risk Factors, Phenotypes, and Management of MASLD-Associated HCC

A Stool DNA–Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population

Expert Consensus on the Post-Procedural Care of Patients After Peroral Endoscopic Myotomy

Continuous Home Terlipressin Infusion Increases Hand Grip Strength and Reduces Ascites in Patients With Cirrhosis

IBD Is an Independent Risk Factor for MASLD in Lean Individuals

Over-the-Scope Clip Fixation, Endoscopic Suture Fixation, and No Fixation for Anchoring Fully Covered Self-Expanding Metal Stents in Benign Upper Gastrointestinal Conditions

Clinical Practice Guidelines on the Management of Patients With MASLD

Emerging Role of GLP-1 Receptor Agonists for the Treatment of MASH

Recently Updated